Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes

S.S. Lund; L. Tarnow; C.D.A. Stehouwer; C.G. Schalkwijk; T. Teerlink; J. Gram; K. Winther; M. Frandsen; U.M. Smidt; O. Pedersen; H.H. Parving; A.A. Vaag

doi:10.1530/EJE-07-0815

Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes

S.S. Lund, L. Tarnow, C.D.A. Stehouwer, C.G. Schalkwijk, T. Teerlink, J. Gram, K. Winther, M. Frandsen, U.M. Smidt, O. Pedersen, H.H. Parving, A.A. Vaag

Clinical chemistry

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	631-641
Journal	European Journal of Endocrinology
Volume	158
Issue number	5
DOIs	https://doi.org/10.1530/EJE-07-0815
Publication status	Published - 2008

Access to Document

10.1530/EJE-07-0815

Cite this

Lund, S. S., Tarnow, L., Stehouwer, C. D. A., Schalkwijk, C. G., Teerlink, T., Gram, J., Winther, K., Frandsen, M., Smidt, U. M., Pedersen, O., Parving, H. H., & Vaag, A. A. (2008). Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes. European Journal of Endocrinology, 158(5), 631-641. https://doi.org/10.1530/EJE-07-0815

@article{0a33d0ace4834247baf13cc674fc56d7,

title = "Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes",

author = "S.S. Lund and L. Tarnow and C.D.A. Stehouwer and C.G. Schalkwijk and T. Teerlink and J. Gram and K. Winther and M. Frandsen and U.M. Smidt and O. Pedersen and H.H. Parving and A.A. Vaag",

year = "2008",

doi = "10.1530/EJE-07-0815",

language = "Undefined/Unknown",

volume = "158",

pages = "631--641",

journal = "European Journal of Endocrinology",

issn = "0804-4643",

publisher = "BioScientifica Ltd.",

number = "5",

}

Lund, SS, Tarnow, L, Stehouwer, CDA, Schalkwijk, CG, Teerlink, T, Gram, J, Winther, K, Frandsen, M, Smidt, UM, Pedersen, O, Parving, HH & Vaag, AA 2008, 'Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes', European Journal of Endocrinology, vol. 158, no. 5, pp. 631-641. https://doi.org/10.1530/EJE-07-0815

Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes. / Lund, S.S.; Tarnow, L.; Stehouwer, C.D.A. et al.

In: European Journal of Endocrinology, Vol. 158, No. 5, 2008, p. 631-641.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes

AU - Lund, S.S.

AU - Tarnow, L.

AU - Stehouwer, C.D.A.

AU - Schalkwijk, C.G.

AU - Teerlink, T.

AU - Gram, J.

AU - Winther, K.

AU - Frandsen, M.

AU - Smidt, U.M.

AU - Pedersen, O.

AU - Parving, H.H.

AU - Vaag, A.A.

PY - 2008

Y1 - 2008

U2 - 10.1530/EJE-07-0815

DO - 10.1530/EJE-07-0815

M3 - Article

C2 - 18426821

VL - 158

SP - 631

EP - 641

JO - European Journal of Endocrinology

JF - European Journal of Endocrinology

SN - 0804-4643

IS - 5

ER -